A modified epirubicin and oxaliplatin plus capecitabine (EOX) regimen as a second- line therapy in patients with advanced gastric cancer

BOZKAYA Y., YILDIRIM ÖZDEMİR N., YAZICI O., DEMİRCİ N. S., KURTİPEK A. C., ERDEM G. U., ...Daha Fazla

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, cilt.19, ss.283-290, 2018 (Scopus)